• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过给予重组凝血因子VIIa来控制对血小板输注治疗难治的Glanzmann血小板无力症患者的严重出血发作。

Control of severe bleeding episode in case of Glanzmann's thrombasthenia refractory to platelet transfusion therapy by administering recombinant factor VIIa.

作者信息

Javed Asim, Ayyub Muhammad, Abrar S, Mansoor M, Khan Badshah, Hussain T

机构信息

Combined Military Hospital, Rawalpindi, Pakistan.

出版信息

J Ayub Med Coll Abbottabad. 2009 Apr-Jun;21(2):171-3.

PMID:20524499
Abstract

Glanzmann's thrombasthenia is an autosomal recessive inherited platelet function defect. Though, quantitatively normal, the aggregation ability of platelets is reduced leading to bleeding episodes requiring transfusion of platelet concentrates. We describe a case of 13-year-old girl who had recurrent episodes of epistaxis since birth and was managed with multiple platelet concentrate transfusions and recently admitted with severe epistaxis refractory to platelet transfusion. At this stage administration of recombinant activated factor VII (fVIIa) was considered, which was initially given at 90 microg/kg dose with little control of bleeding but subsequent second dose of 120 microg/kg was administered with excellent response and immediate control of bleeding.

摘要

血小板无力症是一种常染色体隐性遗传性血小板功能缺陷病。虽然血小板数量正常,但其聚集能力下降,导致出血发作,需要输注血小板浓缩物。我们描述了一名13岁女孩的病例,她自出生以来反复出现鼻出血,接受了多次血小板浓缩物输血治疗,最近因严重鼻出血入院,对血小板输血治疗无效。在此阶段,考虑给予重组活化因子VII(fVIIa),最初以90微克/千克的剂量给药,对出血控制不佳,但随后给予120微克/千克的第二剂,反应良好,出血立即得到控制。

相似文献

1
Control of severe bleeding episode in case of Glanzmann's thrombasthenia refractory to platelet transfusion therapy by administering recombinant factor VIIa.通过给予重组凝血因子VIIa来控制对血小板输注治疗难治的Glanzmann血小板无力症患者的严重出血发作。
J Ayub Med Coll Abbottabad. 2009 Apr-Jun;21(2):171-3.
2
NovoSeven (recombinant factor VIIa) for the treatment of bleeding episodes and perioperative management in patients with Glanzmann's thrombasthenia.诺其(重组凝血因子VIIa)用于治疗血小板无力症患者的出血发作及围手术期管理。
Expert Rev Hematol. 2014 Dec;7(6):733-40. doi: 10.1586/17474086.2014.980811.
3
The use of recombinant factor VIla in a primigravida with Glanzmann's thrombasthenia during delivery.重组凝血因子VIIa在一名患有Glanzmann血小板无力症的初产妇分娩期间的应用。
J Perinat Med. 2004;32(5):456-8. doi: 10.1515/JPM.2004.147.
4
Difficulty in controlling heavy menstrual bleeding at menarche in a patient with Glanzmann's thrombasthenia.初潮时患有 Glanzmann 血小板无力症患者的月经过多难以控制。
Blood Coagul Fibrinolysis. 2021 Mar 1;32(2):155-158. doi: 10.1097/MBC.0000000000000977.
5
The use of recombinant FVIIa in a patient with Glanzmann thrombasthenia with uncontrolled bleeding after tonsillectomy.重组凝血因子VIIa在一名患Glanzmann血小板无力症且扁桃体切除术后出血无法控制的患者中的应用。
Blood Coagul Fibrinolysis. 2009 Apr;20(3):215-7. doi: 10.1097/MBC.0b013e32831d0f69.
6
The international, prospective Glanzmann Thrombasthenia Registry: treatment modalities and outcomes of non-surgical bleeding episodes in patients with Glanzmann thrombasthenia.国际前瞻性血小板无力症注册研究:血小板无力症患者非手术出血事件的治疗方式及结局
Haematologica. 2015 Aug;100(8):1031-7. doi: 10.3324/haematol.2014.121475. Epub 2015 May 22.
7
Successful surgery using recombinant factor VIIa for recurrent, idiopathic nonulcer duodenal bleeding in a patient with Glanzmann's thrombasthenia.使用重组凝血因子VIIa成功治疗一名患有Glanzmann血小板无力症的复发性特发性非溃疡性十二指肠出血患者。
Dig Dis Sci. 2002 Sep;47(9):2134-6. doi: 10.1023/a:1019605803467.
8
Perioperative management of a pediatric patient with Glanzmann's thrombasthenia during adenoidectomy.一名患有Glanzmann血小板无力症的儿科患者在腺样体切除术中的围手术期管理。
Rev Bras Anestesiol. 2012 Jul;62(4):548-53. doi: 10.1016/S0034-7094(12)70154-X.
9
Clinical use of recombinant human activated factor VII (rFVIIa) in the prevention and treatment of bleeding episodes in patients with Glanzmann's thrombasthenia.重组人活化凝血因子VII(rFVIIa)在预防和治疗Glanzmann血小板无力症患者出血发作中的临床应用。
Vasc Health Risk Manag. 2007;3(5):655-64.
10
New Insights Into the Treatment of Glanzmann Thrombasthenia.对血小板无力症治疗的新见解
Transfus Med Rev. 2016 Apr;30(2):92-9. doi: 10.1016/j.tmrv.2016.01.001. Epub 2016 Jan 30.

引用本文的文献

1
Successful Management of Acute Catastrophic Juvenile Vaginal Bleeding in Glanzmann's Thromboasthenia by Uterine Tamponade: A Case Report and Review of The Literature.子宫压迫法成功治疗Glanzmann血小板无力症所致急性灾难性青少年阴道出血:一例报告并文献复习
Case Rep Hematol. 2012;2012:530908. doi: 10.1155/2012/530908. Epub 2012 Mar 20.